nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—BMPR2—ganglion—retroperitoneal cancer	0.0288	0.0288	CbGeAlD
Ruxolitinib—CAMK2G—ganglion—retroperitoneal cancer	0.0258	0.0258	CbGeAlD
Ruxolitinib—LRRK2—ganglion—retroperitoneal cancer	0.0255	0.0255	CbGeAlD
Ruxolitinib—PRKG2—kidney—retroperitoneal cancer	0.0208	0.0208	CbGeAlD
Ruxolitinib—ANKK1—adrenal gland—retroperitoneal cancer	0.0203	0.0203	CbGeAlD
Ruxolitinib—ANKK1—testis—retroperitoneal cancer	0.0168	0.0168	CbGeAlD
Ruxolitinib—PRKCE—adrenal gland—retroperitoneal cancer	0.0157	0.0157	CbGeAlD
Ruxolitinib—PLK1—adrenal gland—retroperitoneal cancer	0.0151	0.0151	CbGeAlD
Ruxolitinib—PRKG2—testis—retroperitoneal cancer	0.0139	0.0139	CbGeAlD
Ruxolitinib—PRKCE—testis—retroperitoneal cancer	0.013	0.013	CbGeAlD
Ruxolitinib—PLK3—adrenal gland—retroperitoneal cancer	0.0126	0.0126	CbGeAlD
Ruxolitinib—RPS6KA6—testis—retroperitoneal cancer	0.0125	0.0125	CbGeAlD
Ruxolitinib—PLK1—testis—retroperitoneal cancer	0.0125	0.0125	CbGeAlD
Ruxolitinib—MAST1—testis—retroperitoneal cancer	0.0125	0.0125	CbGeAlD
Ruxolitinib—JAK1—kidney—retroperitoneal cancer	0.0119	0.0119	CbGeAlD
Ruxolitinib—DCLK3—testis—retroperitoneal cancer	0.0118	0.0118	CbGeAlD
Ruxolitinib—CAMK1—adrenal gland—retroperitoneal cancer	0.0118	0.0118	CbGeAlD
Ruxolitinib—MARK2—adrenal gland—retroperitoneal cancer	0.0114	0.0114	CbGeAlD
Ruxolitinib—HIPK2—kidney—retroperitoneal cancer	0.0112	0.0112	CbGeAlD
Ruxolitinib—TAOK2—adrenal gland—retroperitoneal cancer	0.0106	0.0106	CbGeAlD
Ruxolitinib—PLK3—testis—retroperitoneal cancer	0.0104	0.0104	CbGeAlD
Ruxolitinib—ROCK1—kidney—retroperitoneal cancer	0.0103	0.0103	CbGeAlD
Ruxolitinib—LTK—testis—retroperitoneal cancer	0.0101	0.0101	CbGeAlD
Ruxolitinib—DYRK1A—kidney—retroperitoneal cancer	0.01	0.01	CbGeAlD
Ruxolitinib—BMPR2—kidney—retroperitoneal cancer	0.00999	0.00999	CbGeAlD
Ruxolitinib—CAMK1—testis—retroperitoneal cancer	0.00974	0.00974	CbGeAlD
Ruxolitinib—JAK3—adrenal gland—retroperitoneal cancer	0.00972	0.00972	CbGeAlD
Ruxolitinib—JAK1—adrenal gland—retroperitoneal cancer	0.00966	0.00966	CbGeAlD
Ruxolitinib—DCLK1—adrenal gland—retroperitoneal cancer	0.00966	0.00966	CbGeAlD
Ruxolitinib—PLK4—adrenal gland—retroperitoneal cancer	0.0096	0.0096	CbGeAlD
Ruxolitinib—MARK2—testis—retroperitoneal cancer	0.00945	0.00945	CbGeAlD
Ruxolitinib—CAMK1D—adrenal gland—retroperitoneal cancer	0.00943	0.00943	CbGeAlD
Ruxolitinib—PRKCE—lymph node—retroperitoneal cancer	0.00941	0.00941	CbGeAlD
Ruxolitinib—PHKG2—adrenal gland—retroperitoneal cancer	0.00937	0.00937	CbGeAlD
Ruxolitinib—DAPK2—adrenal gland—retroperitoneal cancer	0.00921	0.00921	CbGeAlD
Ruxolitinib—STK16—adrenal gland—retroperitoneal cancer	0.00906	0.00906	CbGeAlD
Ruxolitinib—PLK1—lymph node—retroperitoneal cancer	0.00904	0.00904	CbGeAlD
Ruxolitinib—RPS6KA6—lymph node—retroperitoneal cancer	0.00904	0.00904	CbGeAlD
Ruxolitinib—HIPK2—adrenal gland—retroperitoneal cancer	0.00902	0.00902	CbGeAlD
Ruxolitinib—LRRK2—kidney—retroperitoneal cancer	0.00886	0.00886	CbGeAlD
Ruxolitinib—TAOK2—testis—retroperitoneal cancer	0.00875	0.00875	CbGeAlD
Ruxolitinib—DAPK3—adrenal gland—retroperitoneal cancer	0.00866	0.00866	CbGeAlD
Ruxolitinib—CLK2—adrenal gland—retroperitoneal cancer	0.00858	0.00858	CbGeAlD
Ruxolitinib—DYRK1A—adrenal gland—retroperitoneal cancer	0.00811	0.00811	CbGeAlD
Ruxolitinib—BMPR2—adrenal gland—retroperitoneal cancer	0.00808	0.00808	CbGeAlD
Ruxolitinib—JAK3—testis—retroperitoneal cancer	0.00804	0.00804	CbGeAlD
Ruxolitinib—DCLK1—testis—retroperitoneal cancer	0.00799	0.00799	CbGeAlD
Ruxolitinib—JAK1—testis—retroperitoneal cancer	0.00799	0.00799	CbGeAlD
Ruxolitinib—PLK4—testis—retroperitoneal cancer	0.00794	0.00794	CbGeAlD
Ruxolitinib—TYK2—kidney—retroperitoneal cancer	0.0079	0.0079	CbGeAlD
Ruxolitinib—CAMK1D—testis—retroperitoneal cancer	0.00779	0.00779	CbGeAlD
Ruxolitinib—PHKG2—testis—retroperitoneal cancer	0.00775	0.00775	CbGeAlD
Ruxolitinib—NUAK2—adrenal gland—retroperitoneal cancer	0.00772	0.00772	CbGeAlD
Ruxolitinib—DAPK2—testis—retroperitoneal cancer	0.00762	0.00762	CbGeAlD
Ruxolitinib—RET—kidney—retroperitoneal cancer	0.0076	0.0076	CbGeAlD
Ruxolitinib—PLK3—lymph node—retroperitoneal cancer	0.00754	0.00754	CbGeAlD
Ruxolitinib—STK16—testis—retroperitoneal cancer	0.00749	0.00749	CbGeAlD
Ruxolitinib—HIPK2—testis—retroperitoneal cancer	0.00746	0.00746	CbGeAlD
Ruxolitinib—MAP3K19—testis—retroperitoneal cancer	0.0073	0.0073	CbGeAlD
Ruxolitinib—LTK—lymph node—retroperitoneal cancer	0.00729	0.00729	CbGeAlD
Ruxolitinib—BMP2K—adrenal gland—retroperitoneal cancer	0.00723	0.00723	CbGeAlD
Ruxolitinib—CAMK2G—adrenal gland—retroperitoneal cancer	0.00723	0.00723	CbGeAlD
Ruxolitinib—JAK2—kidney—retroperitoneal cancer	0.00719	0.00719	CbGeAlD
Ruxolitinib—LRRK2—adrenal gland—retroperitoneal cancer	0.00716	0.00716	CbGeAlD
Ruxolitinib—DAPK3—testis—retroperitoneal cancer	0.00716	0.00716	CbGeAlD
Ruxolitinib—CLK2—testis—retroperitoneal cancer	0.0071	0.0071	CbGeAlD
Ruxolitinib—CAMK1—lymph node—retroperitoneal cancer	0.00706	0.00706	CbGeAlD
Ruxolitinib—ROCK1—testis—retroperitoneal cancer	0.00688	0.00688	CbGeAlD
Ruxolitinib—MARK2—lymph node—retroperitoneal cancer	0.00685	0.00685	CbGeAlD
Ruxolitinib—DYRK1A—testis—retroperitoneal cancer	0.00671	0.00671	CbGeAlD
Ruxolitinib—BMPR2—testis—retroperitoneal cancer	0.00668	0.00668	CbGeAlD
Ruxolitinib—MAP3K2—adrenal gland—retroperitoneal cancer	0.00656	0.00656	CbGeAlD
Ruxolitinib—MAP3K7—adrenal gland—retroperitoneal cancer	0.0065	0.0065	CbGeAlD
Ruxolitinib—TYK2—adrenal gland—retroperitoneal cancer	0.00639	0.00639	CbGeAlD
Ruxolitinib—NUAK2—testis—retroperitoneal cancer	0.00638	0.00638	CbGeAlD
Ruxolitinib—TAOK2—lymph node—retroperitoneal cancer	0.00634	0.00634	CbGeAlD
Ruxolitinib—TAOK3—kidney—retroperitoneal cancer	0.00631	0.00631	CbGeAlD
Ruxolitinib—MKNK2—adrenal gland—retroperitoneal cancer	0.0063	0.0063	CbGeAlD
Ruxolitinib—IRAK1—adrenal gland—retroperitoneal cancer	0.0063	0.0063	CbGeAlD
Ruxolitinib—RET—adrenal gland—retroperitoneal cancer	0.00615	0.00615	CbGeAlD
Ruxolitinib—CAMK2G—testis—retroperitoneal cancer	0.00598	0.00598	CbGeAlD
Ruxolitinib—BMP2K—testis—retroperitoneal cancer	0.00598	0.00598	CbGeAlD
Ruxolitinib—LRRK2—testis—retroperitoneal cancer	0.00592	0.00592	CbGeAlD
Ruxolitinib—JAK3—lymph node—retroperitoneal cancer	0.00583	0.00583	CbGeAlD
Ruxolitinib—JAK2—adrenal gland—retroperitoneal cancer	0.00581	0.00581	CbGeAlD
Ruxolitinib—JAK1—lymph node—retroperitoneal cancer	0.00579	0.00579	CbGeAlD
Ruxolitinib—DCLK1—lymph node—retroperitoneal cancer	0.00579	0.00579	CbGeAlD
Ruxolitinib—PLK4—lymph node—retroperitoneal cancer	0.00575	0.00575	CbGeAlD
Ruxolitinib—CAMK1D—lymph node—retroperitoneal cancer	0.00565	0.00565	CbGeAlD
Ruxolitinib—PHKG2—lymph node—retroperitoneal cancer	0.00562	0.00562	CbGeAlD
Ruxolitinib—MAP3K3—adrenal gland—retroperitoneal cancer	0.0056	0.0056	CbGeAlD
Ruxolitinib—DAPK2—lymph node—retroperitoneal cancer	0.00552	0.00552	CbGeAlD
Ruxolitinib—STK16—lymph node—retroperitoneal cancer	0.00543	0.00543	CbGeAlD
Ruxolitinib—MAP3K2—testis—retroperitoneal cancer	0.00543	0.00543	CbGeAlD
Ruxolitinib—HIPK2—lymph node—retroperitoneal cancer	0.0054	0.0054	CbGeAlD
Ruxolitinib—MAP3K7—testis—retroperitoneal cancer	0.00538	0.00538	CbGeAlD
Ruxolitinib—TYK2—testis—retroperitoneal cancer	0.00528	0.00528	CbGeAlD
Ruxolitinib—MKNK2—testis—retroperitoneal cancer	0.00521	0.00521	CbGeAlD
Ruxolitinib—IRAK1—testis—retroperitoneal cancer	0.00521	0.00521	CbGeAlD
Ruxolitinib—DAPK3—lymph node—retroperitoneal cancer	0.00519	0.00519	CbGeAlD
Ruxolitinib—CLK2—lymph node—retroperitoneal cancer	0.00514	0.00514	CbGeAlD
Ruxolitinib—TAOK3—adrenal gland—retroperitoneal cancer	0.0051	0.0051	CbGeAlD
Ruxolitinib—RET—testis—retroperitoneal cancer	0.00508	0.00508	CbGeAlD
Ruxolitinib—DYRK1A—lymph node—retroperitoneal cancer	0.00486	0.00486	CbGeAlD
Ruxolitinib—BMPR2—lymph node—retroperitoneal cancer	0.00484	0.00484	CbGeAlD
Ruxolitinib—JAK2—testis—retroperitoneal cancer	0.0048	0.0048	CbGeAlD
Ruxolitinib—MAP3K3—testis—retroperitoneal cancer	0.00463	0.00463	CbGeAlD
Ruxolitinib—NUAK2—lymph node—retroperitoneal cancer	0.00463	0.00463	CbGeAlD
Ruxolitinib—CAMK2G—lymph node—retroperitoneal cancer	0.00433	0.00433	CbGeAlD
Ruxolitinib—BMP2K—lymph node—retroperitoneal cancer	0.00433	0.00433	CbGeAlD
Ruxolitinib—LRRK2—lymph node—retroperitoneal cancer	0.00429	0.00429	CbGeAlD
Ruxolitinib—TAOK3—testis—retroperitoneal cancer	0.00422	0.00422	CbGeAlD
Ruxolitinib—MAP3K2—lymph node—retroperitoneal cancer	0.00393	0.00393	CbGeAlD
Ruxolitinib—MAP3K7—lymph node—retroperitoneal cancer	0.0039	0.0039	CbGeAlD
Ruxolitinib—TYK2—lymph node—retroperitoneal cancer	0.00383	0.00383	CbGeAlD
Ruxolitinib—MKNK2—lymph node—retroperitoneal cancer	0.00378	0.00378	CbGeAlD
Ruxolitinib—IRAK1—lymph node—retroperitoneal cancer	0.00378	0.00378	CbGeAlD
Ruxolitinib—RET—lymph node—retroperitoneal cancer	0.00368	0.00368	CbGeAlD
Ruxolitinib—JAK2—lymph node—retroperitoneal cancer	0.00348	0.00348	CbGeAlD
Ruxolitinib—MAP3K3—lymph node—retroperitoneal cancer	0.00336	0.00336	CbGeAlD
Ruxolitinib—TAOK3—lymph node—retroperitoneal cancer	0.00306	0.00306	CbGeAlD
Ruxolitinib—CYP3A4—kidney—retroperitoneal cancer	0.00192	0.00192	CbGeAlD
